Safety and Efficacy of Autologous Bone Marrow Derived Mononuclear Cell Transplant in the Management of Various Neurological Disorders
Autologous BM-MNC therapy appears to be a promising, minimally invasive option for patients with CP, SCI, and MD, which appears to markedly improve functional outcomes and quality of life and may therefore be relevant to clinical practice.
Authors
- Chayanika Kala (ORCID: https://orcid.org/0000-0003-1443-3352)
- Sanjay Kala (ORCID: https://orcid.org/0000-0001-8669-7512)
- Bhagat Singh Rajput (ORCID: https://orcid.org/0000-0003-4128-2553)
- Saptarshi Barman (ORCID: https://orcid.org/0000-0001-6083-5446)
- Anchal Aggarwal
Institutions
- Ganesh Shankar Vidyarthi Memorial Medical College (IN)
Publication Details
- Journal
- Cureus
- Published
- 2024-12-12
- DOI
- https://doi.org/10.7759/cureus.75617
- Primary Topic
- Cerebral Palsy and Movement Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00